Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02UBC
|
|||
| Former ID |
DIB016901
|
|||
| Drug Name |
MEDI6383
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | TAX transcriptionally-activated glycoprotein 1 (OX40) | Target Info | . | [2] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| TSLP Signaling Pathway | ||||
| Reactome | TNFs bind their physiological receptors | |||
| WikiPathways | Vitamin D Receptor Pathway | |||
| TSLP Signaling Pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800041453) | |||
| REF 2 | J Clin Oncol 33, 2015 (suppl; abstr 3056). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.